Submit Deal

VERTEX PHARMACEUTICALS INC

Deals Overview

Total Deals5

Valued Deals5

Total Value£ 5.16 B

Avg. Deal Size£ 1.03 B

Market Context

Senior Management

Reshma Kewalramani
CEO, President & Board Member
Charles Wagner
CFO
Charles F. Wagner
CFO

Sort

06 Jun 2019|United States|Pharmaceuticals

Target: EXONICS THERAPEUTICS INC

Bidder: VERTEX PHARMACEUTICALS INC

3 Service Providers

1 Target | 2 Bidder

13 Dealmakers

3 Target | 10 Bidder

£ 192 M

Value

03 Sep 2019|United States|Pharmaceuticals

Target: SEMMA THERAPEUTICS

Bidder: VERTEX PHARMACEUTICALS INC

3 Service Providers

1 Target | 2 Bidder

26 Dealmakers

2 Target | 24 Bidder

£ 785 M

Value

23 May 2022|United States|Pharmaceuticals

Target: CATALYST BIOSCIENCES (PROTEASE MEDICINE PORTFOLIO)

Bidder: VERTEX PHARMACEUTICALS INC

5 Service Providers

1 Bidder | 4 Vendor

5 Dealmakers

2 Bidder | 3 Vendor

£ 48 M

Value

11 Jul 2022|United States|Biotechnology

Target: VIACYTE

Bidder: VERTEX PHARMACEUTICALS INC

5 Service Providers

3 Target | 2 Bidder

42 Dealmakers

26 Target | 16 Bidder

£ 265 M

Value

10 Apr 2024|United States|Biotechnology

Target: ALPINE IMMUNE SCIENCES INC

Bidder: VERTEX PHARMACEUTICALS INC

8 Service Providers

4 Target | 4 Bidder

58 Dealmakers

37 Target | 21 Bidder

£ 3.87 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management

Reshma Kewalramani
CEO, President & Board Member
Charles Wagner
CFO
Charles F. Wagner
CFO